CMC Expert Kim Raineri Joins Aspen Neuroscience as Chief Technology Officer
prnewswire.com
news
2022-10-19 13:00:00

Company is developing the world's first autologous iPSC manufacturing for Parkinson's patient careSAN DIEGO, Oct. 19, 2022 /PRNewswire/ -- Aspen Neuroscience, Inc., a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson's disease (PD), announced that Kim Raineri has joined the company as Chief Technology Officer and as a member of the company's executive team.


Continue Reading







 






Kim Raineri, Chief Technology Officer, Aspen Neuroscience, Inc.
